18-9887125-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_032243.6(TXNDC2):​c.445C>T​(p.Pro149Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,586,308 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

TXNDC2
NM_032243.6 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -2.29
Variant links:
Genes affected
TXNDC2 (HGNC:16470): (thioredoxin domain containing 2) Enables thioredoxin-disulfide reductase activity. Predicted to be involved in cell differentiation and cellular oxidant detoxification. Predicted to act upstream of or within cellular response to reactive oxygen species and flagellated sperm motility. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.044799358).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TXNDC2NM_032243.6 linkc.445C>T p.Pro149Ser missense_variant Exon 2 of 2 ENST00000357775.6 NP_115619.4 Q86VQ3-2
TXNDC2NM_001098529.2 linkc.646C>T p.Pro216Ser missense_variant Exon 2 of 2 NP_001091999.1 Q86VQ3-1A0A140VJY8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TXNDC2ENST00000357775.6 linkc.445C>T p.Pro149Ser missense_variant Exon 2 of 2 1 NM_032243.6 ENSP00000350419.4 Q86VQ3-2

Frequencies

GnomAD3 genomes
AF:
0.0000992
AC:
14
AN:
141170
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000266
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000139
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000170
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000756
AC:
19
AN:
251392
Hom.:
0
AF XY:
0.0000662
AC XY:
9
AN XY:
135856
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000146
AC:
211
AN:
1445012
Hom.:
0
Cov.:
130
AF XY:
0.000138
AC XY:
99
AN XY:
718808
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000136
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000169
Gnomad4 OTH exome
AF:
0.000320
GnomAD4 genome
AF:
0.0000991
AC:
14
AN:
141296
Hom.:
0
Cov.:
31
AF XY:
0.0000580
AC XY:
4
AN XY:
68978
show subpopulations
Gnomad4 AFR
AF:
0.0000265
Gnomad4 AMR
AF:
0.000139
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000170
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000166
Hom.:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000741
AC:
9
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 18, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.646C>T (p.P216S) alteration is located in exon 2 (coding exon 2) of the TXNDC2 gene. This alteration results from a C to T substitution at nucleotide position 646, causing the proline (P) at amino acid position 216 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
0.019
DANN
Benign
0.33
DEOGEN2
Benign
0.035
.;.;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0051
N
LIST_S2
Benign
0.15
T;T;T
M_CAP
Benign
0.051
D
MetaRNN
Benign
0.045
T;T;T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
1.7
L;.;L
PrimateAI
Benign
0.19
T
PROVEAN
Benign
-1.3
.;N;N
REVEL
Benign
0.26
Sift
Benign
0.33
.;T;T
Sift4G
Benign
0.19
T;T;T
Polyphen
0.15
.;.;B
Vest4
0.062
MVP
0.30
MPC
0.11
ClinPred
0.085
T
GERP RS
-5.0
Varity_R
0.022
gMVP
0.045

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147948919; hg19: chr18-9887122; API